Galaxy Therapeutics

Galaxy Therapeutics is a clinical-stage medical device company based in Milpitas, California, specializing in innovative treatments for brain aneurysms. Founded by four neurointerventional physicians, the company has developed the Seal device, an implant technology aimed at treating wide-neck bifurcation aneurysms, which are particularly challenging cases in neurointervention. The company holds multiple patents in major markets, including the U.S., EU, and China, showcasing its commitment to innovation. Galaxy Therapeutics has recently opened a new manufacturing facility designed to support its transition toward commercial readiness. The facility is equipped with advanced controlled environment rooms and dedicated spaces for research and development, facilitating the scale-up of production. Currently, the Seal device is undergoing clinical investigation through the SEAL IT trial, which evaluates its safety and efficacy. The company is also conducting global clinical programs, including the SEAL™ME registry trial in several countries. Galaxy Therapeutics aims to provide effective medical device solutions to neurointerventional physicians and clinical partners, enhancing patient outcomes in the treatment of brain aneurysms.

• Employees 13